Published in Science on April 20, 1990
Pathogenesis of human immunodeficiency virus infection. Microbiol Rev (1993) 5.88
Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: effects on infectivity and neutralization. J Virol (1991) 3.71
Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc Natl Acad Sci U S A (1998) 3.18
Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120. Proc Natl Acad Sci U S A (1992) 3.02
Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci U S A (1998) 2.89
Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. J Clin Invest (1991) 2.82
Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J Exp Med (1992) 2.48
Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc Natl Acad Sci U S A (1999) 2.40
Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences. J Virol (1994) 2.21
Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease. J Exp Med (1995) 2.11
Localization of simian immunodeficiency virus in the central nervous system of rhesus monkeys. Am J Pathol (1991) 1.93
A femtomolar-acting neuroprotective peptide. J Clin Invest (1996) 1.85
Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc Natl Acad Sci U S A (1993) 1.75
Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1. J Virol (1991) 1.75
Human immunodeficiency virus infection of human brain capillary endothelial cells occurs via a CD4/galactosylceramide-independent mechanism. Proc Natl Acad Sci U S A (1993) 1.73
HIV-associated neurocognitive disorder - pathogenesis and prospects for treatment. Nat Rev Neurol (2016) 1.71
HIV-1 associated dementia: symptoms and causes. Retrovirology (2006) 1.70
Evidence of apoptotic cell death in HIV encephalitis. Am J Pathol (1995) 1.63
The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes. Proc Natl Acad Sci U S A (1993) 1.57
Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin. J Virol (1994) 1.56
Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patients. J Virol (1998) 1.52
Temporal patterns of human immunodeficiency virus type 1 transcripts in human fetal astrocytes. J Virol (1994) 1.50
Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. Proc Natl Acad Sci U S A (1997) 1.46
Neuronal apoptosis is mediated by CXCL10 overexpression in simian human immunodeficiency virus encephalitis. Am J Pathol (2004) 1.40
Apoptosis induced by HIV-1 infection of the central nervous system. J Clin Invest (1996) 1.40
Apoptotic death of striatal neurons induced by human immunodeficiency virus-1 Tat and gp120: Differential involvement of caspase-3 and endonuclease G. J Neurovirol (2004) 1.38
gp120-induced neurotoxicity in hippocampal pyramidal neuron cultures: protective action of TGF-beta1. J Neurosci (1996) 1.34
Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1. J Virol (1992) 1.32
Neuropsychological assessment of HIV-infected populations in international settings. Neuropsychol Rev (2009) 1.31
Tumor necrosis factor-alpha at the crossroads of neuronal life and death during HIV-associated dementia. J Neurochem (2003) 1.31
HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuse. J Neurochem (2006) 1.31
Chemokine receptor utilization by human immunodeficiency virus type 1 isolates that replicate in microglia. J Virol (1998) 1.30
Free radicals as mediators of neuronal injury. Cell Mol Neurobiol (1998) 1.28
A model of human immunodeficiency virus encephalitis in scid mice. Proc Natl Acad Sci U S A (1993) 1.25
Cocaine and human immunodeficiency virus type 1 gp120 mediate neurotoxicity through overlapping signaling pathways. J Neurovirol (2009) 1.23
Synaptic dysfunction in the hippocampus accompanies learning and memory deficits in human immunodeficiency virus type-1 Tat transgenic mice. Biol Psychiatry (2012) 1.19
Apoptosis of uninfected cells induced by HIV envelope glycoproteins. Retrovirology (2004) 1.16
Increased CDK5 expression in HIV encephalitis contributes to neurodegeneration via tau phosphorylation and is reversed with Roscovitine. Am J Pathol (2011) 1.15
Envelope glycoprotein gp120 of human immunodeficiency virus type 1 alters ion transport in astrocytes: implications for AIDS dementia complex. Proc Natl Acad Sci U S A (1994) 1.14
Monocyte adhesion to endothelium in simian immunodeficiency virus-induced AIDS encephalitis is mediated by vascular cell adhesion molecule-1/alpha 4 beta 1 integrin interactions. Am J Pathol (1994) 1.14
Neuronal density in the superior frontal and temporal gyri does not correlate with the degree of human immunodeficiency virus-associated dementia. Acta Neuropathol (1994) 1.14
Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: protection by the antioxidant N-acetylcysteine and the genes bcl-2 and crmA. Mol Cell Biol (1995) 1.14
Envelope glycoproteins of human immunodeficiency virus type 1: profound influences on immune functions. Microbiol Rev (1996) 1.13
Murine retroviral neurovirulence correlates with an enhanced ability ofvirus to infect selectively, replicate in, and activate resident microglial cells. Am J Pathol (1991) 1.11
HIV's double strike at the brain: neuronal toxicity and compromised neurogenesis. Front Biosci (2008) 1.11
Neuronal number and volume alterations in the neocortex of HIV infected individuals. J Neurol Neurosurg Psychiatry (1993) 1.09
Low levels of human immunodeficiency virus replication in the brain tissue of children with severe acquired immunodeficiency syndrome encephalopathy. Am J Pathol (1992) 1.08
Immunoglobulins from animal models of motor neuron disease and from human amyotrophic lateral sclerosis patients passively transfer physiological abnormalities to the neuromuscular junction. Proc Natl Acad Sci U S A (1991) 1.07
Platelet-derived growth factor protects neurons against gp120-mediated toxicity. J Neurovirol (2008) 1.07
HIV-infected macrophages mediate neuronal apoptosis through mitochondrial glutaminase. J Neurochem (2007) 1.04
Immune activation, viral gene product expression and neurotoxicity in the HIV-1 transgenic rat. J Neuroimmunol (2012) 1.02
Morphine and gp120 toxic interactions in striatal neurons are dependent on HIV-1 strain. J Neuroimmune Pharmacol (2011) 1.02
Induction of rapid and extensive beta-chemokine synthesis in macrophages by human immunodeficiency virus type 1 and gp120, independently of their coreceptor phenotype. J Virol (2001) 1.02
Nigral degeneration in acquired immune deficiency syndrome (AIDS). Acta Neuropathol (1991) 1.01
HIV-1 gp120 and drugs of abuse: interactions in the central nervous system. Curr HIV Res (2012) 0.98
HIV-1, methamphetamine and astrocyte glutamate regulation: combined excitotoxic implications for neuro-AIDS. Curr HIV Res (2012) 0.98
Human immunodeficiency virus type 1 infection of neural xenografts. Proc Natl Acad Sci U S A (1992) 0.98
CXCL12 signaling in the development of the nervous system. J Neuroimmune Pharmacol (2012) 0.98
Neuronal damage in the cerebral cortex of AIDS brains: a morphometric study. Acta Neuropathol (1993) 0.96
Human immunodeficiency virus type 1 infection of the brain. Clin Microbiol Rev (1993) 0.94
Mechanisms of platelet-derived growth factor-mediated neuroprotection--implications in HIV dementia. Eur J Neurosci (2008) 0.94
Human CNS cultures exposed to HIV-1 gp120 reproduce dendritic injuries of HIV-1-associated dementia. J Neuroinflammation (2004) 0.93
Converging roles for sphingolipids and cell stress in the progression of neuro-AIDS. Front Biosci (2008) 0.92
HIV neuropathogenesis: a tight rope walk of innate immunity. J Neuroimmune Pharmacol (2010) 0.92
The whole-cell calcium current in acutely dissociated magnocellular cholinergic basal forebrain neurones of the rat. J Physiol (1993) 0.92
The human immunodeficiency virus coat protein gp120 promotes forward trafficking and surface clustering of NMDA receptors in membrane microdomains. J Neurosci (2011) 0.91
Nitric oxide synthesis enhances human immunodeficiency virus replication in primary human macrophages. J Virol (2000) 0.91
Enhancement of human immunodeficiency virus 1 replication in monocytes by 1,25-dihydroxycholecalciferol. Proc Natl Acad Sci U S A (1991) 0.90
Neuronal pattern correlates with the severity of human immunodeficiency virus-associated dementia complex. Usefulness of spatial pattern analysis in clinicopathological studies. Am J Pathol (1996) 0.90
Up-regulation of the neuronal nicotinic receptor α7 by HIV glycoprotein 120: potential implications for HIV-associated neurocognitive disorder. J Biol Chem (2011) 0.90
Expression of human immunodeficiency virus type 1 in the nervous system of transgenic mice leads to neurological disease. J Virol (1994) 0.89
Sequences regulating tropism of human immunodeficiency virus type 1 for brain capillary endothelial cells map to a unique region on the viral genome. J Virol (1996) 0.89
Methamphetamine abuse, HIV infection, and neurotoxicity. Int J Physiol Pathophysiol Pharmacol (2009) 0.87
Viral diseases of the central nervous system. Curr Opin Virol (2015) 0.87
The chemokine CXCL12 and the HIV-1 envelope protein gp120 regulate spontaneous activity of Cajal-Retzius cells in opposite directions. J Physiol (2012) 0.86
Molecular Mechanisms of Neurodegenerative Diseases Induced by Human Retroviruses: A Review. Am J Infect Dis (2009) 0.86
Platelet-derived growth factor CC-mediated neuroprotection against HIV Tat involves TRPC-mediated inactivation of GSK 3beta. PLoS One (2012) 0.86
Reduced genetic diversity in lymphoid and central nervous system tissues and selection-induced tissue-specific compartmentalization of neuropathogenic SIVsmmFGb during acute infection. AIDS Res Hum Retroviruses (2009) 0.85
Endocrine modulation of the neurotoxicity of gp120: implications for AIDS-related dementia complex. Proc Natl Acad Sci U S A (1997) 0.84
HIV Associated Neurocognitive Disorders. Infect Dis Rep (2013) 0.84
Suppression of immunodeficiency virus-associated neural damage by the p75 neurotrophin receptor ligand, LM11A-31, in an in vitro feline model. J Neuroimmune Pharmacol (2011) 0.84
Mitogen-activated protein kinase p38 in HIV infection and associated brain injury. J Neuroimmune Pharmacol (2011) 0.83
HIV-1 gp120-induced axonal injury detected by accumulation of β-amyloid precursor protein in adult rat corpus callosum. J Neuroimmune Pharmacol (2011) 0.83
Effects of feline immunodeficiency virus on astrocyte glutamate uptake: implications for lentivirus-induced central nervous system diseases. Proc Natl Acad Sci U S A (1998) 0.82
Cytotoxic effect of HIV-1 coat glycoprotein gp120 on human neuroblastoma CHP100 cells involves activation of the arachidonate cascade. Biochem J (1998) 0.82
A mechanism of restricted human immunodeficiency virus type 1 expression in human glial cells. J Virol (1996) 0.82
Neuronal expression of human immunodeficiency virus type 1 env proteins in transgenic mice: distribution in the central nervous system and pathological alterations. J Virol (1995) 0.81
PTEN gene silencing prevents HIV-1 gp120(IIIB)-induced degeneration of striatal neurons. J Neurovirol (2011) 0.81
HIV-1 coat protein gp120 stimulates interleukin-1beta secretion from human neuroblastoma cells: evidence for a role in the mechanism of cell death. Br J Pharmacol (2001) 0.80
Gp120 in the pathogenesis of human immunodeficiency virus-associated pain. Ann Neurol (2014) 0.79
In vivo transcriptional regulation of the human immunodeficiency virus in the central nervous system in transgenic mice. J Virol (1996) 0.79
HIV Subtypes B and C gp120 and Methamphetamine Interaction: Dopaminergic System Implicates Differential Neuronal Toxicity. Sci Rep (2015) 0.79
GPI-1046 protects dorsal root ganglia from gp120-induced axonal injury by modulating store-operated calcium entry. J Peripher Nerv Syst (2009) 0.79
Effects of opiates and HIV proteins on neurons: the role of ferritin heavy chain and a potential for synergism. Curr HIV Res (2012) 0.79
Inhibition of murine embryonic growth by human immunodeficiency virus envelope protein and its prevention by vasoactive intestinal peptide and activity-dependent neurotrophic factor. J Clin Invest (1997) 0.79
Borna disease virus persistence causes inhibition of glutamate uptake by feline primary cortical astrocytes. J Virol (2000) 0.79
HIV gp120 inhibits the somatotropic axis: a possible GH-releasing hormone receptor mechanism for the pathogenesis of AIDS wasting. Proc Natl Acad Sci U S A (1998) 0.77
Human immunodeficiency virus and its effects on the visual system. Infect Dis Rep (2012) 0.77
The role of tau protein in HIV-associated neurocognitive disorders. Mol Neurodegener (2014) 0.76
In vitro and animal models of human immunodeficiency virus infection of the central nervous system. Clin Diagn Lab Immunol (2002) 0.76
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ (2008) 10.45
Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ (2011) 9.44
Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature (2001) 5.60
Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci U S A (1995) 4.84
Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature (2001) 4.35
Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat Med (1998) 4.09
Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron (1995) 4.07
(S)NO signals: translocation, regulation, and a consensus motif. Neuron (1997) 3.67
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ (2009) 3.44
Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A. Nature (1998) 2.59
HIV-1 infection and AIDS: consequences for the central nervous system. Cell Death Differ (2005) 2.54
Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex. Neuron (1992) 2.54
hMEF2C gene encodes skeletal muscle- and brain-specific transcription factors. Mol Cell Biol (1993) 2.41
Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc Natl Acad Sci U S A (1999) 2.40
Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity. J Neurosci (1992) 2.25
Molecular basis of NMDA receptor-coupled ion channel modulation by S-nitrosylation. Nat Neurosci (2000) 2.24
Activation of the Keap1/Nrf2 pathway for neuroprotection by electrophilic [correction of electrophillic] phase II inducers. Proc Natl Acad Sci U S A (2006) 2.15
Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease. J Exp Med (1995) 2.11
MEF2C, a MADS/MEF2-family transcription factor expressed in a laminar distribution in cerebral cortex. Proc Natl Acad Sci U S A (1993) 2.07
The neuropathogenesis of HIV-1 infection. J Leukoc Biol (1994) 1.83
Mitochondrial fission is an upstream and required event for bax foci formation in response to nitric oxide in cortical neurons. Cell Death Differ (2006) 1.77
Assembly with the NR1 subunit is required for surface expression of NR3A-containing NMDA receptors. J Neurosci (2001) 1.75
Molecular basis of glutamate toxicity in retinal ganglion cells. Vision Res (1997) 1.74
Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron (1991) 1.73
Developmental and regional expression pattern of a novel NMDA receptor-like subunit (NMDAR-L) in the rodent brain. J Neurosci (1995) 1.70
Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism. J Physiol (1997) 1.66
Selective modulation of NMDA responses by reduction and oxidation. Neuron (1989) 1.64
Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol (1996) 1.64
Identification and mechanism of action of two histidine residues underlying high-affinity Zn2+ inhibition of the NMDA receptor. Neuron (1999) 1.62
New perspectives on glaucoma. JAMA (1999) 1.60
Neurotransmitter regulation of neuronal outgrowth, plasticity and survival. Trends Neurosci (1989) 1.59
Treatment strategies and visual acuity outcomes in chronic postoperative Propionibacterium acnes endophthalmitis. Ophthalmology (1999) 1.55
Antiapoptotic role of the p38 mitogen-activated protein kinase-myocyte enhancer factor 2 transcription factor pathway during neuronal differentiation. Proc Natl Acad Sci U S A (2000) 1.52
Mitochondrial and extramitochondrial apoptotic signaling pathways in cerebrocortical neurons. Proc Natl Acad Sci U S A (2000) 1.51
Identification of two cysteine residues that are required for redox modulation of the NMDA subtype of glutamate receptor. Neuron (1994) 1.50
HIV-1 coreceptors CCR5 and CXCR4 both mediate neuronal cell death but CCR5 paradoxically can also contribute to protection. Cell Death Differ (2006) 1.50
Electrical and adaptive properties of rod photoreceptors in Bufo marinus. II. Effects of cyclic nucleotides and prostaglandins. J Gen Physiol (1977) 1.50
Mice deficient in Mac-1 (CD11b/CD18) are less susceptible to cerebral ischemia/reperfusion injury. Stroke (1999) 1.42
NMDA receptors: from genes to channels. Trends Pharmacol Sci (1996) 1.36
Role of p38 mitogen-activated protein kinase in axotomy-induced apoptosis of rat retinal ganglion cells. J Neurosci (2000) 1.34
Cloning of a gamma-aminobutyric acid type C receptor subunit in rat retina with a methionine residue critical for picrotoxinin channel block. Proc Natl Acad Sci U S A (1995) 1.31
Monoclonal antibody to Thy-1 enhances regeneration of processes by rat retinal ganglion cells in culture. Science (1984) 1.30
A phase I/II trial of nimodipine for HIV-related neurologic complications. Neurology (1998) 1.27
Redox modulation by S-nitrosylation contributes to protein misfolding, mitochondrial dynamics, and neuronal synaptic damage in neurodegenerative diseases. Cell Death Differ (2011) 1.25
Attenuation of NMDA receptor activity and neurotoxicity by nitroxyl anion, NO-. Neuron (1999) 1.24
N-methyl-D-aspartate receptors are critical for mediating the effects of glutamate on intracellular calcium concentration and immediate early gene expression in cultured hippocampal neurons. Neuroscience (1995) 1.20
Molecular stages of rapid and uniform neuralization of human embryonic stem cells. Cell Death Differ (2009) 1.19
Chronic low-dose glutamate is toxic to retinal ganglion cells. Toxicity blocked by memantine. Invest Ophthalmol Vis Sci (1996) 1.15
Multiple GABA receptor subtypes mediate inhibition of calcium influx at rat retinal bipolar cell terminals. J Neurosci (1995) 1.15
Three pairs of cysteine residues mediate both redox and zn2+ modulation of the nmda receptor. J Neurosci (2001) 1.14
Cytoskeletal breakdown and apoptosis elicited by NO donors in cerebellar granule cells require NMDA receptor activation. J Neurochem (1996) 1.13
Structure and function of GABA(C) receptors: a comparison of native versus recombinant receptors. Trends Pharmacol Sci (2001) 1.12
Electrical and adaptive properties of rod photoreceptors in Bufo marinus. I. Effects of altered extracellular Ca2+ levels. J Gen Physiol (1977) 1.11
Role of caspases in N-methyl-D-aspartate-induced apoptosis in cerebrocortical neurons. J Neurochem (1998) 1.11
Redox modulatory site of the NMDA receptor-channel complex: regulation by oxidized glutathione. J Neurosci Res (1991) 1.09
A syndrome of asymmetric limb weakness with motor conduction block. Neurology (1990) 1.08
Responses mediated by excitatory amino acid receptors in solitary retinal ganglion cells from rat. J Physiol (1988) 1.08
Photoreceptor status after antivascular endothelial growth factor therapy in exudative age-related macular degeneration. Br J Ophthalmol (2009) 1.06
Functional role and therapeutic implications of neuronal caspase-1 and -3 in a mouse model of traumatic spinal cord injury. Neuroscience (2000) 1.04
Synergistic activation of the N-methyl-D-aspartate receptor subunit 1 promoter by myocyte enhancer factor 2C and Sp1. J Biol Chem (1998) 1.03
Redox modulation of the NMDA receptor. Cell Mol Life Sci (2000) 1.02
Candidal infection in the central nervous system. Am J Med (1984) 1.02
Shakespeare in love--with NMDA receptors? Nat Med (1999) 1.02
Calcium channels in solitary retinal ganglion cells from post-natal rat. J Physiol (1989) 1.02
Differential modulation by sulfhydryl redox agents and glutathione of GABA- and glycine-evoked currents in rat retinal ganglion cells. J Neurosci (1995) 1.01
Involvement of activated caspase-3-like proteases in N-methyl-D-aspartate-induced apoptosis in cerebrocortical neurons. J Neurochem (2000) 1.00
Macular translocation for subfoveal choroidal neovascularization in age-related macular degeneration: a prospective study. Am J Ophthalmol (1999) 0.99
Blockade of electrical activity promotes the death of mammalian retinal ganglion cells in culture. Proc Natl Acad Sci U S A (1986) 0.99
Neuronal necrosis and apoptosis: two distinct events induced by exposure to glutamate or oxidative stress. Adv Neurol (1997) 0.98
Paradigm shift in neuroprotective drug development: clinically tolerated NMDA receptor inhibition by memantine. Cell Death Differ (2004) 0.98
Neuronal injury due to HIV-1 envelope protein is blocked by anti-gp120 antibodies but not by anti-CD4 antibodies. Neurology (1990) 0.98
Molecular mechanisms of nitrosative stress-mediated protein misfolding in neurodegenerative diseases. Cell Mol Life Sci (2007) 0.97
The interaction of agonists and noncompetitive antagonists at the excitatory amino acid receptors in rat retinal ganglion cells in vitro. J Neurosci (1988) 0.97
Aberrant RNA splicing in sporadic amyotrophic lateral sclerosis. Neuron (1998) 0.96
Intercellular adhesion molecule-1-deficient mice are less susceptible to cerebral ischemia-reperfusion injury. Ann Neurol (1996) 0.96
Vision: the additivity law made to work for heterochromatic photometry with bipartite fields. Science (1968) 0.96
VEGF inhibitors for the treatment of neovascular age-related macular degeneration. Expert Opin Investig Drugs (2009) 0.96
Redox modulation of NMDA receptor-mediated toxicity in mammalian central neurons. Neurosci Lett (1990) 0.94
Suppression of neuronal apoptosis by S-nitrosylation of caspases. Neurosci Lett (1997) 0.94
Photodynamic therapy of circumscribed choroidal haemangioma. Br J Ophthalmol (2004) 0.94
Human immunodeficiency virus-infected macrophages, gp120, and N-methyl-D-aspartate receptor-mediated neurotoxicity. Ann Neurol (1993) 0.93
Cytokine-stimulated, but not HIV-infected, human monocyte-derived macrophages produce neurotoxic levels of l -cysteine. J Immunol (2000) 0.93
S-Nitrosylation and uncompetitive/fast off-rate (UFO) drug therapy in neurodegenerative disorders of protein misfolding. Cell Death Differ (2007) 0.93
Agonist-induced closure of constitutively open gamma-aminobutyric acid channels with mutated M2 domains. Proc Natl Acad Sci U S A (1997) 0.93
Excitotoxins in neuronal apoptosis and necrosis. J Cereb Blood Flow Metab (1999) 0.93
The effect of arteriovenous sheathotomy on cystoid macular oedema secondary to branch retinal vein occlusion. Br J Ophthalmol (2003) 0.92
Neurothekeoma palpebrae: a rare nerve sheath tumor arising in the eyelid. Ophthal Plast Reconstr Surg (1999) 0.92
Janus faces of NF-kappa B: neurodestruction versus neuroprotection. Nat Med (1997) 0.92
Delayed administration of memantine prevents N-methyl-D-aspartate receptor-mediated neurotoxicity. Ann Neurol (1993) 0.92
Characterization of GABA- and glycine-induced currents of solitary rodent retinal ganglion cells in culture. Neuroscience (1988) 0.91
Nitrate therapy may retard glaucomatous optic neuropathy, perhaps through modulation of glutamate receptors. Vision Res (1998) 0.90
Nitrosative and oxidative stress links dysfunctional ubiquitination to Parkinson's disease. Cell Death Differ (2005) 0.90
Corticosteroid therapy for optic disc neovascularization secondary to chronic uveitis. Am J Ophthalmol (2000) 0.90
Nitric oxide-related species inhibit evoked neurotransmission but enhance spontaneous miniature synaptic currents in central neuronal cultures. Proc Natl Acad Sci U S A (1996) 0.89
Potential and current use of N-methyl-D-aspartate (NMDA) receptor antagonists in diseases of aging. Drugs Aging (2001) 0.89
The coat protein gp120 of HIV-1 inhibits astrocyte uptake of excitatory amino acids via macrophage arachidonic acid. Eur J Neurosci (1995) 0.89
Desensitization of GABA-activated currents and channels in cultured cortical neurons. J Neurosci (1992) 0.89
Constant hue loci of unique and binary balanced hues at 10, 100, and 1000 Td. J Opt Soc Am A (1987) 0.89